Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Proteasome 20S catalytic core subunit is a central component of the proteasome complex, responsible for regulated protein degradation in eukaryotic cells. The 20S core particle (CP) forms the heart of the larger 26S proteasome and can also function independently. It is a barrel-shaped structure composed of four stacked heptameric rings, with two outer α-rings and two inner β-rings. The β-subunits contain threonine residues that act as nucleophiles in peptide bond hydrolysis, providing chymotrypsin-like, trypsin-like, and caspase-like enzymatic activities. The primary role is ATP-independent degradation of damaged or misfolded proteins and regulatory proteins no longer needed by the cell, maintaining protein homeostasis. Access to the catalytic chamber is tightly controlled by gating mechanisms. Dysregulation is implicated in various diseases. Components like the β-subunits serve as drug targets for cancer therapies such as bortezomib.
Inhibition of chymotrypsin-like activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 20S Catalytic Core Subunit (20S Proteasome).